Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

Oral and topical tofacitinib can help regrow hair in people with severe alopecia areata.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Afatinib often causes skin problems that need proactive management.

Tofacitinib is effective and safe for treating alopecia areata.

Combining finasteride and terazosin can cause severe allergic reactions.

Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Combining α1-blockers with 5α-reductase inhibitors improves urinary symptoms in men.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

Early diagnosis and treatment of EGFR inhibitor-induced folliculitis decalvans can prevent permanent hair loss.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.